NCT07507877 Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness
| NCT ID | NCT07507877 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Sepsis |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2026-04-04 |
| Primary Completion | 2026-11-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2026-04-04 with a primary completion date of 2026-11-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Fluid responsiveness refers to the ability of the left ventricle to significantly increase stroke volume following fluid administration, and its assessment is critical in managing acute circulatory failure while avoiding fluid overload.Infraclavicular axillary vein collapsibility index is a substitute for inferior vena cava collapsibility index in assessment for the need of fluid resuscitation in spontaneously breathing sepsis related acute circulatory failure patients.
Eligibility Criteria
Inclusion Criteria: * Adult patients ≥18 years. * Patients with sepsis must meet at least two or more criteria of systemic inflammatory response syndrome (SIRS). * Spontaneously breathing patients. * Clinical signs of acute circulatory failure. Exclusion Criteria: * Patients below the age of 18 years. * Mechanically ventilated patients
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07507877 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sepsis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07507877 currently recruiting?
Yes, NCT07507877 is actively recruiting participants. Contact the research team at ibrahim_mamdouh@med.asu.edu.eg for enrollment information.
Where is the NCT07507877 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07507877 clinical trial?
NCT07507877 is sponsored by Ain Shams University. The trial plans to enroll 40 participants.